Ask the Experts Forum: Implementing Lumit® Immunoassays
This webinar is Part 3 of the Lumit™ Technology Webinar Series.
In this Forum, you will be able to:
- Hear directly from other users of Lumit™ technology
- Listen to Promega Technical Services scientists answer frequently asked questions
Summary
Lumit™ Technology Webinar Series
Immunoassays are an essential tool for life science researchers, widely used for decades. Applying bioluminescent technology to this well-accepted assay format to create Lumit™ Immunoassays has made analyte detection faster and easier than ever before. This webinar series will introduce you to Lumit™ Immunoassay technology and highlight key research areas where bioluminescent immunoassays have supported research discoveries.
Part 3: Ask the Experts Forum: Implementing Lumit™ Immunoassays
In the third part of this series, join other Lumit™ users and experts for an interactive panel discussion on immunoassay technology. R&D scientists and Technical Service Scientists will discuss frequently asked questions with immunoassays.
Other Webinars in this Series:
Bioluminescent Analyte Detection with Lumit™ Immunoassays
Using Lumit™ Technology to Address Inflammasome-mediated Cytokine Release
Advances in Glucagon Detection Supporting Diabetes and Metabolic Disorder Research
Speakers
![3530-lazar-dan-125x125](https://scv10mr-cdnpre-p-cus-00.azureedge.net/-/media/images/resources/speaker-images/2020/3530-lazar-dan-125x125.jpg?rev=13a407c11f3e48a19580d48edca425cc&sc_lang=es-es)
Dan Lazar, PhD
Senior Research Scientist
Dr. Dan Lazar received his Ph.D. in biological chemistry from the University of Michigan and then completed a postdoctoral fellowship focused on cell signaling at Warner Lambert/Parke-Davis. Subsequently, he was a Team Leader and Senior Scientist at Eli Lilly within the metabolic disease drug-discovery area for well over a decade where he gained extensive experience in the development, validation and implementation of cell-based and biochemical assays for drug discovery. As a Group Leader and Senior Research Scientist at Promega, Dan and his colleagues are principally focused on delivering novel cell-based assays for the quantitative assessment of various aspects of cell health to assist academic and industrial investigators.
![700obrienmartha125x125](https://scv10mr-cdnpre-p-cus-00.azureedge.net/-/media/images/resources/speaker-images/2020/700obrienmartha125x125.jpg?rev=bdfadeb6a1664b35a09ba728f51707d1&sc_lang=es-es)
Martha O'Brien, PhD
Senior Research Scientist
![2464-zegzouti-hicham-125x125](https://scv10mr-cdnpre-p-cus-00.azureedge.net/-/media/images/resources/speaker-images/2020/2464-zegzouti-hicham-125x125.jpg?rev=645de34868e448fd96d8643bcf95b1cb&sc_lang=es-es)
Hicham Zegzouti, PhD
Senior Research Scientist
![mishler-elmore-john-125](https://scv10mr-cdnpre-p-cus-00.azureedge.net/-/media/images/resources/speaker-images/2023/mishler-elmore-john-125.jpg?rev=6cb43aba83154353a6922684868d3819&sc_lang=es-es)
John Mishler-Elmore, PhD
Technical Services Scientist